| Product Name | MF | CAS | Details |
|---|
| MAT2A-IN-10 | C27H24F2N6O4 | 2924825-23-8 | Details |
| JG-23 | C19H16ClN3OS2 | 2640819-75-4 | Details |
| PD-L1-IN-2 | C33H38N4O6 | 2894733-91-4 | Details |
| WH-10417-099 | C52H62N8O13S | 2769753-42-4 | Details |
| SC239 | C65H84N10O11 | 1977557-97-3 | Details |
| P2X3-IN-1 | 2823331-49-1 | Details |
| CHI-000-667 | C21H16ClNO4S | 905794-70-9 | Details |
| Fosnetupitant chloride monohydrochloride | C31H36F6N4O5P. HCl. Cl | 1643757-72-5 | Details |
| MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan | C54H58FN9O13 | 2414254-41-2 | Details |
| KRAS G12D mutation regulator 4 | C33H33FN6O2 | 2621927-57-7 | Details |
| vc-PABC-DM1 | C53H75ClN8O13S | 1416792-90-9 | Details |
| GSK737 | C20H21N5O2 | 2748687-95-6 | Details |
| IDO1/TDO-IN-6 | C20H17NO5 | 2948772-71-0 | Details |
| β-catenin-IN-6 | C22H19ClN6O | 1039731-99-1 | Details |
| GGFG-amide-glycol-amide-Exatecan | C43H47FN8O11 | 2866301-18-8 | Details |
| Antitumor agent-97 | C24H34O3 | 2654024-16-3 | Details |
| Nrf2-IN-3 | C22H26N4O4S | 6325-13-9 | Details |
| TAM558 | C79H122N14O19S | 1802499-21-3 | Details |
| (1R,4S)-Yimitasvir diphosphate | 2734870-15-4 | Details |
| Nurr1 agonist 4 | C12H10O4 | 87645-58-7 | Details |
| (RS)-K20 | 2915618-92-5 | Details |
| BET-IN-14 | C30H37N7O2 | 2243669-93-2 | Details |
| Antifungal agent 48 | C13H10O4S | 2142003-75-4 | Details |
| QR-0217 | C19H13NO3 | 1027786-12-4 | Details |
| FHND5071 | C30H30D3N9O | 2761152-16-1 | Details |
| Antifungal agent 50 | C25H20ClN5O2S | 2896209-33-7 | Details |
| MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D | C44H51ClN6O10 | 2222445-87-4 | Details |
| Clezutoclax | C83H102N12O24S2 | 1949843-71-3 | Details |
| (R)-Necrocide 1 | C23H27NO3 | 1247028-62-1 | Details |
| UZH1b | C32H42N6O3 | 2814392-17-9 | Details |
| Val-Ala-PABC-Exatecan | 2845164-91-0 | Details |
| Urease-IN-6 | C18H19N3OS | 362502-79-2 | Details |
| Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) | C55H94N10O31 | 2360920-01-8 | Details |
| Azilsartan mepixetil potassium | C36H34N6O8.K | 2153458-32-1 | Details |
| SN38-COOH | C26H24N2O8 | 2170118-23-5 | Details |
| XMT-1519 conjugate-1 | C101H149N23O42 | 2720500-19-4 | Details |
| COX-2-IN-30 | 1160498-08-7 | Details |
| SIMR3030 | C27H29N3O2 | 2708270-99-7 | Details |
| INX-SM-6 | C32H36N2O6S | 2734878-16-9 | Details |
| (S,R)-CFT8634 | C37H45F3N6O5 | 2704617-95-6 | Details |
| TrkB-IN-1 | C19H16N2O6 | 1609067-49-3 | Details |
| PPARδ agonist 9 | C26H28ClF3N4O3S | 928023-21-6 | Details |
| VU0364739 | C26H27FN4O2 | 1244639-78-8 | Details |
| DNA Gyrase-IN-8 | C19H14BrN5O | 2925308-76-3 | Details |
| DprE1-IN-9 | 2906099-98-5 | Details |
| JAK-IN-26 | C22H24N6O3 | 2417134-93-9 | Details |
| NSC 288387 | C19H16N4O3 | 61369-43-5 | Details |
| Necrocide 1 | C23H27NO3 | 1247028-61-0 | Details |
| CYT296 | C18H16O2S | 1799392-31-6 | Details |
| Mal-PEG8-Val-Ala-PAB-Exatecan | C66H85FN8O20 | 2679821-39-5 | Details |
| ZL-2201 | C19H21N9O2.CH4O3S | 2865115-39-3 | Details |
| MAO-IN-3 | C42H54N4O4 | 797805-26-6 | Details |
| (Aminooxy)acetamide-Val-Cit-PAB-MMAE | C60H97N11O14 | 2446645-88-9 | Details |
| MEL24 | C17H18N4O3 | 642072-48-8 | Details |
| PI5P4Kα-IN-1 | C20H17N3O2S | 2428737-31-7 | Details |
| KRAS G12C mutant protein inhibitor A-1 | C31H26ClF4N7O2 | 2658538-04-4 | Details |
| Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE | C67H101N11O16 | 1638970-46-3 | Details |
| I-287 | C30H30ClFN4O4 | 2014368-93-3 | Details |
| PBR28 | C21H20N2O3 | 253307-65-2 | Details |
| Osivelotor | C20H22N2O6 | 2417955-18-9 | Details |
| Propargyl-PEG4-GGFG-DXd | C54H63FN8O15 | 2762518-94-3 | Details |
| Glucocerebrosidase-IN-1 hydrochloride | 2279945-77-4 | Details |
| Ferric nitrilotriacetate | C6H6FeNO6 | 16448-54-7 | Details |
| AChE-IN-31 | 1325209-07-1 | Details |
| D1R antagonist 1 | C22H26BrNO4 | 2983777-67-7 | Details |
| HDAC-IN-59 | 2944459-43-0 | Details |
| JT002 | C20H24N4O5S | 2238820-43-2 | Details |
| NH2-methylpropanamide-Exatecan TFA | C28H29FN4O5.C2HF3O2 | 1817857-35-4 | Details |
| SHP2-IN-22 | 2802453-88-7 | Details |
| CCT374705 | C21H18ClF3N4O2 | 2640647-90-9 | Details |
| VEGFR2-IN-3 | C26H28ClN5O4 | 417717-09-0 | Details |
| NK3R-IN-1 | C17H16FN5OS | 2854331-14-7 | Details |
| Xeniafaraunol A | C20H28O2 | 161162-29-4 | Details |
| PRMT5-IN-29 | C18H19Cl2N5O5.ClH | 2242788-69-6 | Details |
| (2S,3R)-Voruciclib hydrochloride | C22H19ClF3NO5.ClH | 1253647-46-9 | Details |
| α-Glucosidase-IN-28 | 2949513-10-2 | Details |
| AM841 | C26H39NO3S | 871978-21-1 | Details |
| STAT3 degrader-2 | C59H62N9O13P | 2497583-03-4 | Details |
| ZINC00784494 | C20H14N2O3S | 317328-17-9 | Details |
| GPR52 receptor modulator 1 | C19H14F4N4O | 2642079-89-6 | Details |
| SA09-Cu | 155641-16-0 | Details |
| MKA031 | C21H17N5O2S | 2951012-00-1 | Details |
| GSK217 | C20H20N6O | 2748687-92-3 | Details |
| Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan | C57H65FN10O15 | 1599439-54-9 | Details |
| NaPi2b-IN-2 | C41H47ClF3N5O5S | 2227445-31-8 | Details |
| α-Glucosidase-IN-29 | 2949513-11-3 | Details |
| Glucocorticoid receptor agonist-2 Ala-Ala-Mal | C47H50F2N4O12 | 2166376-64-1 | Details |
| Maytansinoid B | C36H51ClN4O10 | 1628543-40-7 | Details |
| HP210 | C22H19N3O2S2 | 728039-52-9 | Details |
| Farletuzumab ecteribulin | 2407465-18-1 | Details |
| Antifungal agent 49 | C15H12O4 | 1414861-21-4 | Details |
| HDAC-IN-60 | 2944459-58-7 | Details |
| H3B-968 | C22H18F6N4O4S | 2912294-90-5 | Details |
| Mps1-IN-6 (Compound 9) | C24H27N7O2 | 2489220-49-5 | Details |
| FLT3-IN-19 | C22H26N8O | 2237234-48-7 | Details |
| IDO1-IN-22 | 2126853-16-3 | Details |
| Anticancer agent 105 | C25H25N3O6S.K | 2450987-57-0 | Details |
| A-1293102 | 1565759-96-7 | Details |
| BET-IN-16 | 2089390-09-8 | Details |
| Val-Ala-PAB-MMAE | C55H88N8O11 | 1912408-92-4 | Details |
| Product Total： Product Page： | ||||
| 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||